|
US3065143A
(en)
|
1960-04-19 |
1962-11-20 |
Richardson Merrell Inc |
Sustained release tablet
|
|
US3260646A
(en)
|
1962-10-19 |
1966-07-12 |
Ferring Ab |
Medication with mechanism to prevent overdosage
|
|
DE2530563C2
(de)
|
1975-07-09 |
1986-07-24 |
Bayer Ag, 5090 Leverkusen |
Analgetische Arzneimittel mit vermindertem Mißbrauchspotential
|
|
US4175119A
(en)
|
1978-01-11 |
1979-11-20 |
Porter Garry L |
Composition and method to prevent accidental and intentional overdosage with psychoactive drugs
|
|
US4221778A
(en)
|
1979-01-08 |
1980-09-09 |
Pennwalt Corporation |
Prolonged release pharmaceutical preparations
|
|
US4457933A
(en)
|
1980-01-24 |
1984-07-03 |
Bristol-Myers Company |
Prevention of analgesic abuse
|
|
US4389393A
(en)
|
1982-03-26 |
1983-06-21 |
Forest Laboratories, Inc. |
Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
|
|
US4459278A
(en)
|
1983-03-07 |
1984-07-10 |
Clear Lake Development Group |
Composition and method of immobilizing emetics and method of treating human beings with emetics
|
|
US4599342A
(en)
|
1984-01-16 |
1986-07-08 |
The Procter & Gamble Company |
Pharmaceutical products providing enhanced analgesia
|
|
US4610870A
(en)
|
1984-10-05 |
1986-09-09 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US4666705A
(en)
|
1985-06-03 |
1987-05-19 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
US4800083A
(en)
|
1986-10-20 |
1989-01-24 |
R. P. Scherer Corporation |
Sustained release method and product
|
|
US4801461A
(en)
|
1987-01-28 |
1989-01-31 |
Alza Corporation |
Pseudoephedrine dosage form
|
|
US4915952A
(en)
|
1987-02-27 |
1990-04-10 |
Alza Corporation |
Composition comprising drug, HPC, HPMC and PEO
|
|
US5073380A
(en)
|
1987-07-27 |
1991-12-17 |
Mcneil-Ppc, Inc. |
Oral sustained release pharmaceutical formulation and process
|
|
US5330766A
(en)
|
1989-01-06 |
1994-07-19 |
F. H. Faulding & Co. Limited |
Sustained release pharmaceutical composition
|
|
US5114942A
(en)
|
1989-03-31 |
1992-05-19 |
Yale University |
Treating habit disorders
|
|
US5059600A
(en)
|
1989-03-31 |
1991-10-22 |
Yale University |
Treating habit disorders
|
|
US5084278A
(en)
|
1989-06-02 |
1992-01-28 |
Nortec Development Associates, Inc. |
Taste-masked pharmaceutical compositions
|
|
US5075114A
(en)
|
1990-05-23 |
1991-12-24 |
Mcneil-Ppc, Inc. |
Taste masking and sustained release coatings for pharmaceuticals
|
|
US5284662A
(en)
|
1990-10-01 |
1994-02-08 |
Ciba-Geigy Corp. |
Oral osmotic system for slightly soluble active agents
|
|
US5098715A
(en)
|
1990-12-20 |
1992-03-24 |
Burroughs Wellcome Co. |
Flavored film-coated tablet
|
|
US5273758A
(en)
|
1991-03-18 |
1993-12-28 |
Sandoz Ltd. |
Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
|
|
US5405617A
(en)
|
1991-11-07 |
1995-04-11 |
Mcneil-Ppc, Inc. |
Aliphatic or fatty acid esters as a solventless carrier for pharmaceuticals
|
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
|
US5431916A
(en)
|
1993-04-29 |
1995-07-11 |
The Procter & Gamble Company |
Pharmaceutical compositions and process of manufacture thereof
|
|
US5484606A
(en)
|
1994-01-24 |
1996-01-16 |
The Procter & Gamble Company |
Process for reducing the precipitation of difficulty soluble pharmaceutical actives
|
|
GB9401894D0
(en)
|
1994-02-01 |
1994-03-30 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
|
NZ280610A
(en)
|
1994-12-29 |
1997-08-22 |
Mcneil Ppc Inc |
Soft gelatin-like pharmaceutical carrier: gelled polyethylene glycol and dispersed active agent
|
|
US5660859A
(en)
|
1994-12-29 |
1997-08-26 |
Mcneil-Ppc, Inc. |
Gelling agent for polyethylene glycol
|
|
IL116674A
(en)
|
1995-01-09 |
2003-05-29 |
Mendell Co Inc Edward |
Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
|
|
US5558879A
(en)
|
1995-04-28 |
1996-09-24 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation for water soluble drugs in which a passageway is formed in situ
|
|
US5654005A
(en)
|
1995-06-07 |
1997-08-05 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation having a preformed passageway
|
|
US5807579A
(en)
|
1995-11-16 |
1998-09-15 |
F.H. Faulding & Co. Limited |
Pseudoephedrine combination pharmaceutical compositions
|
|
MX9807594A
(en)
|
1996-04-10 |
1999-03-31 |
Warner Lambert Co |
Denaturants for sympathomimetic amine salts
|
|
US5858409A
(en)
|
1996-04-17 |
1999-01-12 |
Fmc Corporation |
Hydrolyzed cellulose granulations for pharmaceuticals
|
|
EP2065055A1
(en)
|
1996-06-26 |
2009-06-03 |
Board of Regents, The University of Texas System |
Holt-melt extrudable pharmaceutical formulation
|
|
US5919481A
(en)
|
1996-06-28 |
1999-07-06 |
Ncneil-Ppc, Inc. |
Fill material for soft gelatin pharmaceutical dosage form
|
|
US6024980A
(en)
|
1996-06-28 |
2000-02-15 |
Mcneil-Ppc, Inc. |
Multiphase soft gelatin dosage form
|
|
US6361796B1
(en)
|
1996-10-25 |
2002-03-26 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
|
US6027746A
(en)
|
1997-04-23 |
2000-02-22 |
Warner-Lambert Company |
Chewable soft gelatin-encapsulated pharmaceutical adsorbates
|
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
|
ES2203963T3
(es)
|
1997-05-30 |
2004-04-16 |
Osmotica Corp. |
Dispositivo osmotico multicapa.
|
|
US6153621A
(en)
|
1997-06-23 |
2000-11-28 |
The University Of Kentucky Research Foundation |
Combined antagonist compositions
|
|
US5895663A
(en)
|
1997-07-31 |
1999-04-20 |
L. Perrigo Company |
Pseudoephedrine hydrochloride extended-release tablets
|
|
DE19740983A1
(de)
|
1997-09-18 |
1999-04-08 |
Warner Lambert Co N D Ges D St |
Verfahren zur Erschwerung der Extraktion von Wirkstoffen aus Tabletten
|
|
US6607751B1
(en)
|
1997-10-10 |
2003-08-19 |
Intellipharamaceutics Corp. |
Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
|
|
US5955107A
(en)
|
1997-12-12 |
1999-09-21 |
Fmc Corporation |
Pharmaceutical suspension tablet compositions
|
|
US20030059471A1
(en)
|
1997-12-15 |
2003-03-27 |
Compton Bruce Jon |
Oral delivery formulation
|
|
CN1204890C
(zh)
|
1997-12-22 |
2005-06-08 |
欧罗赛铁克股份有限公司 |
防止阿片样物质滥用的方法
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
US6432442B1
(en)
|
1998-02-23 |
2002-08-13 |
Mcneil-Ppc, Inc. |
Chewable product
|
|
US6495529B1
(en)
|
1998-07-01 |
2002-12-17 |
Warner-Lambert Company |
(−)-Pseudoephedrine as a sympathomimetic drug
|
|
US6541520B1
(en)
|
1998-08-05 |
2003-04-01 |
Brookhaven Science Associates |
Treatment of addiction and addiction-related behavior
|
|
US6270790B1
(en)
|
1998-08-18 |
2001-08-07 |
Mxneil-Ppc, Inc. |
Soft, convex shaped chewable tablets having reduced friability
|
|
US5997905A
(en)
|
1998-09-04 |
1999-12-07 |
Mcneil-Ppc |
Preparation of pharmaceutically active particles
|
|
GT199900148A
(es)
|
1998-09-10 |
2001-02-28 |
|
Desnaturalizantes para las sales aminas simpaticomimeticas.
|
|
US7906143B1
(en)
|
1998-10-05 |
2011-03-15 |
Intellipharmaceutics Corp |
Controlled release pharmaceutical delivery device and process for preparation thereof
|
|
EP1005863A1
(en)
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
US20030170181A1
(en)
|
1999-04-06 |
2003-09-11 |
Midha Kamal K. |
Method for preventing abuse of methylphenidate
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
US6500459B1
(en)
|
1999-07-21 |
2002-12-31 |
Harinderpal Chhabra |
Controlled onset and sustained release dosage forms and the preparation thereof
|
|
US6541025B1
(en)
|
1999-12-30 |
2003-04-01 |
Shear/Kershman Laboratories, Inc. |
Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
|
|
US6340471B1
(en)
|
1999-12-30 |
2002-01-22 |
Alvin Kershman |
Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
|
|
US6613357B2
(en)
|
2000-01-13 |
2003-09-02 |
Osmotica Corp. |
Osmotic device containing pseudoephedrine and an H1 antagonist
|
|
US6491949B2
(en)
|
2000-01-14 |
2002-12-10 |
Osmotica Corp. |
Osmotic device within an osmotic device
|
|
US6352721B1
(en)
|
2000-01-14 |
2002-03-05 |
Osmotica Corp. |
Combined diffusion/osmotic pumping drug delivery system
|
|
US6277409B1
(en)
|
2000-02-11 |
2001-08-21 |
Mcneil-Ppc, Inc. |
Protective coating for tablet
|
|
US6551617B1
(en)
|
2000-04-20 |
2003-04-22 |
Bristol-Myers Squibb Company |
Taste masking coating composition
|
|
WO2001080826A2
(en)
*
|
2000-04-20 |
2001-11-01 |
Bristol-Myers Squibb Company |
Taste masking coating composition
|
|
US6926892B2
(en)
|
2000-05-18 |
2005-08-09 |
Hmv Corporation |
Protecting plants from oomycete pathogens by treatment with compositions containing serratamolide and oocydin a from Serratia marcescens
|
|
US6607748B1
(en)
|
2000-06-29 |
2003-08-19 |
Vincent Lenaerts |
Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
|
|
US6375982B1
(en)
|
2000-07-05 |
2002-04-23 |
Capricorn Pharma, Inc. |
Rapid-melt semi-solid compositions, methods of making same and method of using same
|
|
US20100010101A1
(en)
|
2000-07-05 |
2010-01-14 |
Capricorn Pharma, Inc. |
Rapid-Melt Compositions and Methods of Making Same
|
|
US20020022057A1
(en)
|
2000-08-17 |
2002-02-21 |
Battey Alyce S. |
Oral delivery of pharmaceuticals via encapsulation
|
|
US20030049320A1
(en)
|
2000-12-18 |
2003-03-13 |
Wockhardt Limited |
Novel in-situ forming controlled release microcarrier delivery system
|
|
US20020119196A1
(en)
|
2000-12-21 |
2002-08-29 |
Narendra Parikh |
Texture masked particles containing an active ingredient
|
|
US6800668B1
(en)
|
2001-01-19 |
2004-10-05 |
Intellipharmaceutics Corp. |
Syntactic deformable foam compositions and methods for making
|
|
US6559159B2
(en)
|
2001-02-01 |
2003-05-06 |
Research Triangle Institute |
Kappa opioid receptor ligands
|
|
ES2265022T3
(es)
|
2001-03-14 |
2007-02-01 |
Pfizer Products Inc. |
Comprimido farmaceutico y procedimiento para su fabricacion.
|
|
US20030004177A1
(en)
|
2001-05-11 |
2003-01-02 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant opioid dosage form
|
|
US20030064122A1
(en)
|
2001-05-23 |
2003-04-03 |
Endo Pharmaceuticals, Inc. |
Abuse resistant pharmaceutical composition containing capsaicin
|
|
JP2004532257A
(ja)
|
2001-05-31 |
2004-10-21 |
シーマ・ラブス、インコーポレイテッド |
高水溶性薬剤のテイスト・マスキング
|
|
US6524618B1
(en)
|
2001-06-12 |
2003-02-25 |
Vijai Kumar |
Directly compressible extended-release matrix formulation for metformin hydrochloride
|
|
WO2003004009A1
(en)
|
2001-07-02 |
2003-01-16 |
Geneva Pharmaceuticals, Inc. |
Pharmaceutical composition
|
|
US7144587B2
(en)
|
2001-08-06 |
2006-12-05 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
|
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
US7157103B2
(en)
|
2001-08-06 |
2007-01-02 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing irritant
|
|
US7842307B2
(en)
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
|
US7141250B2
(en)
|
2001-08-06 |
2006-11-28 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing bittering agent
|
|
WO2003020242A1
(en)
|
2001-08-29 |
2003-03-13 |
Srl Technologies, Inc. |
Sustained release preparations
|
|
US20030049272A1
(en)
|
2001-08-30 |
2003-03-13 |
Yatindra Joshi |
Pharmaceutical composition which produces irritation
|
|
US20030050620A1
(en)
|
2001-09-07 |
2003-03-13 |
Isa Odidi |
Combinatorial type controlled release drug delivery device
|
|
US20030068276A1
(en)
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
|
US6592901B2
(en)
|
2001-10-15 |
2003-07-15 |
Hercules Incorporated |
Highly compressible ethylcellulose for tableting
|
|
WO2003039561A1
(en)
|
2001-11-02 |
2003-05-15 |
Elan Corporation, Plc |
Pharmaceutical composition
|
|
US7101572B2
(en)
|
2001-12-07 |
2006-09-05 |
Unilab Pharmatech, Ltd. |
Taste masked aqueous liquid pharmaceutical composition
|
|
KR100540035B1
(ko)
|
2002-02-01 |
2005-12-29 |
주식회사 태평양 |
다단계 경구 약물 방출 제어 시스템
|
|
AU2003224419A1
(en)
|
2002-02-20 |
2003-09-09 |
Strides Arcolab Limited |
Orally administrable pharmaceutical formulation
|
|
US8323692B2
(en)
|
2002-02-21 |
2012-12-04 |
Valeant International Bermuda |
Controlled release dosage forms
|
|
US6753009B2
(en)
|
2002-03-13 |
2004-06-22 |
Mcneil-Ppc, Inc. |
Soft tablet containing high molecular weight polyethylene oxide
|
|
US20050106249A1
(en)
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
|
WO2003101431A1
(en)
|
2002-06-04 |
2003-12-11 |
J.B. Chemicals & Pharmaceuticals Ltd. |
Pharmaceutical composition for controlled drug delivery system
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
WO2004002445A2
(en)
|
2002-06-26 |
2004-01-08 |
Cadila Healthcare Limited |
Novel floating dosage form
|
|
EP2422773A3
(en)
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Sequestering subunit and related compositions and methods
|
|
AU2003272601B2
(en)
|
2002-09-20 |
2009-05-07 |
Alpharma Pharmaceuticals, Llc |
Sustained-release opioid formulations and methods of use
|
|
US20040081695A1
(en)
|
2002-09-28 |
2004-04-29 |
Sowden Harry S |
Dosage forms having an inner core and an outer shell
|
|
US7192966B2
(en)
|
2002-11-15 |
2007-03-20 |
Branded Products For The Future |
Pharmaceutical composition
|
|
US20040109889A1
(en)
|
2002-12-04 |
2004-06-10 |
Bunick Frank J. |
Surface treatment composition for soft substrates
|
|
US8293799B2
(en)
|
2003-12-29 |
2012-10-23 |
Osmotica Keresleedelmo és Szolgáltató KFT |
Osmotic device containing a venlafaxine salt and a salt having an ion in common
|
|
US7524515B2
(en)
|
2003-01-10 |
2009-04-28 |
Mutual Pharmaceuticals, Inc. |
Pharmaceutical safety dosage forms
|
|
US20040185097A1
(en)
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
|
EP2186510B1
(en)
|
2003-03-26 |
2013-07-10 |
Egalet Ltd. |
Matrix compositions for controlled delivery of drug substances
|
|
AU2004238321B2
(en)
|
2003-05-07 |
2009-08-27 |
Samyang Biopharmaceuticals Corporation |
Highly plastic granules for making fast melting tablets
|
|
US8906413B2
(en)
|
2003-05-12 |
2014-12-09 |
Supernus Pharmaceuticals, Inc. |
Drug formulations having reduced abuse potential
|
|
US20040265372A1
(en)
|
2003-06-27 |
2004-12-30 |
David Wynn |
Soft tablet containing high molecular weight cellulosics
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
DE102004020220A1
(de)
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
NZ545145A
(en)
|
2003-08-06 |
2009-07-31 |
Nirmal Mulye |
Pharmaceutical composition containing water soluble drug
|
|
US7611728B2
(en)
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
TW201509943A
(zh)
|
2004-03-30 |
2015-03-16 |
Euro Celtique Sa |
含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
|
AU2005245027B2
(en)
|
2004-05-21 |
2011-05-19 |
Accu-Break Technologies, Inc. |
Pharmaceutical tablets having a separation mark positioned on the side of said tablets
|
|
ES2624585T3
(es)
|
2004-05-28 |
2017-07-17 |
Imaginot Pty Ltd. |
Sistema de suministro de compuesto terapéutico oral
|
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
|
WO2006017159A1
(en)
|
2004-07-09 |
2006-02-16 |
Drugtech Corporation |
Controlled phase composition technology as an improved process for protection of drugs
|
|
US20060018837A1
(en)
|
2004-07-26 |
2006-01-26 |
Victory Pharma, Inc. |
Pharmaceutical compositions and methods for the prevention of drug misuse
|
|
US9308176B2
(en)
*
|
2004-10-15 |
2016-04-12 |
Supernus Pharmaceuticals, Inc |
Less abusable pharmaceutical preparations
|
|
US7389393B1
(en)
|
2004-10-21 |
2008-06-17 |
Symantec Operating Corporation |
System and method for write forwarding in a storage environment employing distributed virtualization
|
|
US20060093631A1
(en)
|
2004-10-29 |
2006-05-04 |
Buehler Gail K |
Dye-free pharmaceutical suspensions and related methods
|
|
US20060105038A1
(en)
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
|
US20060177380A1
(en)
|
2004-11-24 |
2006-08-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20060110327A1
(en)
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US20080152595A1
(en)
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
EP1906937B1
(en)
|
2005-07-22 |
2016-10-19 |
Rubicon Research Pvt Ltd. |
Novel dispersible tablet composition
|
|
US9125833B2
(en)
|
2005-11-02 |
2015-09-08 |
Relmada Therapeutics, Inc. |
Multimodal abuse resistant and extended release opioid formulations
|
|
CA2629904C
(en)
|
2005-11-28 |
2018-07-10 |
Imaginot Pty Ltd. |
Oral therapeutic compound delivery system
|
|
US20070134493A1
(en)
|
2005-12-08 |
2007-06-14 |
Kanji Meghpara |
Compositions and capsules with stable hydrophilic layers
|
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
ZA200807571B
(en)
|
2006-03-01 |
2009-08-26 |
Ethypharm Sa |
Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion
|
|
EP2018160B1
(en)
|
2006-03-16 |
2011-12-14 |
Tris Pharma, Inc. |
Modified release formulations containing drug-ion exchange resin complexes
|
|
JP5535616B2
(ja)
|
2006-03-31 |
2014-07-02 |
ルビコン リサーチ プライベート リミテッド |
口腔内崩壊錠剤のための直接圧縮性複合材
|
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
|
AU2007261098A1
(en)
|
2006-06-19 |
2007-12-27 |
Mcneil-Ppc, Inc. |
Enteric coated particles containing an active ingredient
|
|
WO2008008434A1
(en)
|
2006-07-11 |
2008-01-17 |
Mutual Pharmaceutical Company, Inc. |
Controlled-release formulations
|
|
EP2043613A1
(en)
|
2006-07-14 |
2009-04-08 |
Fmc Corporation |
Solid form
|
|
US20080214619A1
(en)
*
|
2006-07-29 |
2008-09-04 |
Wolfe M Michael |
Business method to treat and/or prevent a gastric acid disorder with a proton pump inhibitor (PPI) and a cholinergic agonist to induce rapid onset of PPI action with or without food
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
KR101468053B1
(ko)
|
2006-08-31 |
2014-12-02 |
앱탈리스 파마테크, 인코포레이티드 |
약 염기성 약물의 고용체를 포함하는 약물 전달 시스템
|
|
BRPI0716481A2
(pt)
|
2006-09-04 |
2014-03-18 |
Panacea Biotec Ltd |
Tecnologia de liberação flutuante programável
|
|
US20080260837A1
(en)
|
2007-04-20 |
2008-10-23 |
Qpharma, L.L.C. |
Physically stable aqueous suspensions of active pharmaceuticals
|
|
RU2472493C2
(ru)
|
2007-05-08 |
2013-01-20 |
Геркулес Инкорпорейтед |
Композиция прочной быстро распадающейся таблетки
|
|
ES2612032T3
(es)
|
2007-06-04 |
2017-05-11 |
Shear/Kershman Laboratories, Inc. |
Formas farmacéuticas orales basadas en lípidos inviolables para agonistas opiáceos
|
|
US20090004281A1
(en)
|
2007-06-26 |
2009-01-01 |
Biovail Laboratories International S.R.L. |
Multiparticulate osmotic delivery system
|
|
PL2200588T3
(pl)
|
2007-09-25 |
2019-09-30 |
Solubest Ltd. |
Kompozycje zawierające lipofilowe związki aktywne i sposób ich wytwarzania
|
|
US20090081291A1
(en)
|
2007-09-26 |
2009-03-26 |
Gin Jerry B |
Sustained Release Dosage Forms For Delivery of Agents to an Oral Cavity of a User
|
|
PL2572705T3
(pl)
|
2007-10-01 |
2018-01-31 |
Lesvi Laboratorios Sl |
Tabletki ulegające rozpadowi w jamie ustnej
|
|
WO2009066146A2
(en)
|
2007-11-19 |
2009-05-28 |
Cadila Pharmaceuticals Ltd. |
Stable solutions of sparingly soluble actives
|
|
CA2707980C
(en)
|
2007-12-17 |
2015-05-12 |
Labopharm Inc. |
Misuse preventative, controlled release formulation
|
|
EP2229156B1
(en)
|
2007-12-20 |
2016-11-09 |
Fertin Pharma A/S |
Chewing gum tablet and method of dosing pharmaceutically active ingredients in such chewing gum tablet
|
|
WO2009080022A1
(en)
|
2007-12-20 |
2009-07-02 |
Fertin Pharma A/S |
Compressed chewing gum tablet
|
|
KR20100134557A
(ko)
|
2008-01-11 |
2010-12-23 |
씨아이피엘에이 엘티디. |
고체 약제학적 투여 제형
|
|
US8383152B2
(en)
|
2008-01-25 |
2013-02-26 |
Gruenenthal Gmbh |
Pharmaceutical dosage form
|
|
US8420700B1
(en)
|
2008-06-04 |
2013-04-16 |
James M. Bausch |
Tamper resistant lipid-based oral dosage form for sympathomimetic amines
|
|
WO2010044842A1
(en)
*
|
2008-10-16 |
2010-04-22 |
University Of Tennessee Research Foundation |
Tamper resistant oral dosage forms containing an embolizing agent
|
|
US20100260842A1
(en)
|
2009-04-06 |
2010-10-14 |
Rashmi Nair |
Pseudoephedrine pharmaceutical formulations
|
|
AU2010242748B2
(en)
|
2009-05-01 |
2015-07-23 |
Adare Pharmaceuticals, Inc. |
Orally disintegrating tablet compositions comprising combinations of high and low-dose drugs
|
|
WO2010132204A1
(en)
*
|
2009-05-12 |
2010-11-18 |
Bpsi Holdings, Llc. |
Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
|
|
US8901113B2
(en)
|
2009-09-30 |
2014-12-02 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
|
JP5854476B2
(ja)
*
|
2009-11-30 |
2016-02-09 |
アデア ファーマスーティカルズ，インコーポレイテッド |
圧縮性コーティングで被覆された医薬組成物及び錠剤並びに製造方法
|
|
EP2509631A4
(en)
*
|
2009-12-10 |
2014-04-02 |
Monosol Rx Llc |
PH-SENSITIVE COMPOUNDS FOR MASKING THE TASTE OF ORAL STRIPS IN THE FORM OF THIN FILM
|
|
US20130022646A1
(en)
*
|
2010-02-09 |
2013-01-24 |
Rudnic Edward M |
Controlled Release Formulations of Opioids
|
|
US9125867B2
(en)
|
2010-02-24 |
2015-09-08 |
Invincible Biotechnology |
Diversion- and/or abuse-resistant compositions and methods for making the same
|
|
GB201020895D0
(en)
*
|
2010-12-09 |
2011-01-26 |
Euro Celtique Sa |
Dosage form
|
|
FR2968995B1
(fr)
*
|
2010-12-16 |
2013-03-22 |
Sanofi Aventis |
Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
|
|
CA2852042C
(en)
*
|
2012-03-02 |
2018-05-01 |
Rhodes Pharmaceuticals L.P. |
Tamper resistant immediate release formulations
|
|
CN104379174B
(zh)
*
|
2012-06-22 |
2018-01-26 |
巴斯夫欧洲公司 |
基于甲基丙烯酸二乙基氨基乙酯共聚物的含活性成分固体分散体
|
|
CN104968333B
(zh)
*
|
2012-11-30 |
2018-07-10 |
阿库拉制药公司 |
活性药物成分的自调节释放
|
|
WO2014145195A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Cerovene, Inc. |
Pharmaceuticals comprising a ph-dependent component and ph-raising agent
|
|
WO2015065547A1
(en)
|
2013-10-31 |
2015-05-07 |
Cima Labs Inc. |
Immediate release abuse-deterrent granulated dosage forms
|
|
EP3122336A4
(en)
*
|
2014-03-26 |
2017-10-25 |
Sun Pharma Advanced Research Company Ltd |
Abuse deterrent immediate release biphasic matrix solid dosage form
|